Baxter

Baxter was founded in 1931 and has been a leader in healthcare for more than 75 years. Baxter assists healthcare professionals and their patients with treatment of complex medical conditions. Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2009 sales of $12.6 billion and has approximately 49,700 employees. In 1996, Baxter spun off its health-care products and cost-management services into a new, independent, publicly traded company they named Allegiance Healthcare Corporation, renewing its focus on its core technologies of renal technology, biotechnology, and medication delivery. Allegiance distributed Baxter's intravenous solutions and other products in the United States, while Baxter marketed and distributed Allegiance's products in many overseas markets. In 1999, Cardinal Health acquired Allegiance Healthcare. Many Baxter products are now supplied under the distributor Cardinal Health. For more information of Baxter's product spin-offs and its merge with Cardinal Health and Allegiance, please click here.